vs
KVH INDUSTRIES INC \DE\（KVHI）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是KVH INDUSTRIES INC \DE\的1.2倍（$35.5M vs $30.5M），KVH INDUSTRIES INC \DE\净利率更高（1.1% vs -304.2%，领先305.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 13.4%），KVH INDUSTRIES INC \DE\自由现金流更多（$1.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 2.1%）
KVH工业公司是一家专注于惯性导航系统、卫星通信解决方案及运动传感产品研发、生产与销售的全球化科技企业，核心客户覆盖航空航天、国防、海事运输、自动驾驶等领域，业务遍及北美、欧洲及亚太地区。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
KVHI vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.5M | $35.5M |
| 净利润 | $331.0K | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -3.0% | -304.8% |
| 净利率 | 1.1% | -304.2% |
| 营收同比 | 13.4% | 681.7% |
| 净利润同比 | 107.7% | 39.6% |
| 每股收益（稀释后） | $0.02 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $30.5M | $35.5M | ||
| Q3 25 | $28.5M | $5.2M | ||
| Q2 25 | $26.6M | $19.2M | ||
| Q1 25 | $25.4M | $14.7M | ||
| Q4 24 | $26.9M | $4.5M | ||
| Q3 24 | $29.0M | $26.1M | ||
| Q2 24 | $28.7M | $14.4M | ||
| Q1 24 | $29.3M | $13.8M |
| Q4 25 | $331.0K | $-108.1M | ||
| Q3 25 | $-6.9M | $-162.3M | ||
| Q2 25 | $930.0K | $-171.9M | ||
| Q1 25 | $-1.7M | $-202.5M | ||
| Q4 24 | $-4.3M | $-178.9M | ||
| Q3 24 | $-1.2M | $-95.8M | ||
| Q2 24 | $-2.4M | $-97.5M | ||
| Q1 24 | $-3.2M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -3.0% | -304.8% | ||
| Q3 25 | -26.8% | -3327.6% | ||
| Q2 25 | -1.4% | -916.8% | ||
| Q1 25 | -8.8% | -1297.9% | ||
| Q4 24 | -11.9% | -4042.4% | ||
| Q3 24 | -6.9% | -377.1% | ||
| Q2 24 | -10.1% | -697.4% | ||
| Q1 24 | -13.0% | -698.4% |
| Q4 25 | 1.1% | -304.2% | ||
| Q3 25 | -24.4% | -3135.3% | ||
| Q2 25 | 3.5% | -894.2% | ||
| Q1 25 | -6.7% | -1373.3% | ||
| Q4 24 | -16.0% | -3935.5% | ||
| Q3 24 | -4.1% | -367.5% | ||
| Q2 24 | -8.3% | -676.6% | ||
| Q1 24 | -10.8% | -662.4% |
| Q4 25 | $0.02 | $-0.17 | ||
| Q3 25 | $-0.36 | $-0.36 | ||
| Q2 25 | $0.05 | $-0.41 | ||
| Q1 25 | $-0.09 | $-0.50 | ||
| Q4 24 | $-0.23 | $-0.56 | ||
| Q3 24 | $-0.06 | $-0.34 | ||
| Q2 24 | $-0.12 | $-0.40 | ||
| Q1 24 | $-0.16 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.9M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $131.0M | $1.1B |
| 总资产 | $151.5M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $69.9M | $743.3M | ||
| Q3 25 | $72.8M | $659.8M | ||
| Q2 25 | $55.9M | $525.1M | ||
| Q1 25 | $48.6M | $500.5M | ||
| Q4 24 | $50.6M | $594.4M | ||
| Q3 24 | $49.8M | $427.6M | ||
| Q2 24 | $49.3M | $474.3M | ||
| Q1 24 | $66.6M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $131.0M | $1.1B | ||
| Q3 25 | $131.0M | $1.0B | ||
| Q2 25 | $138.4M | $919.1M | ||
| Q1 25 | $137.8M | $933.9M | ||
| Q4 24 | $138.6M | $1.0B | ||
| Q3 24 | $142.7M | $524.6M | ||
| Q2 24 | $143.4M | $584.4M | ||
| Q1 24 | $145.1M | $401.2M |
| Q4 25 | $151.5M | $1.5B | ||
| Q3 25 | $150.3M | $1.4B | ||
| Q2 25 | $152.0M | $1.3B | ||
| Q1 25 | $151.4M | $1.3B | ||
| Q4 24 | $155.1M | $1.4B | ||
| Q3 24 | $166.7M | $726.5M | ||
| Q2 24 | $168.9M | $775.9M | ||
| Q1 24 | $168.4M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $1.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | 3.4% | -133.1% |
| 资本支出强度资本支出/营收 | 7.7% | 3.5% |
| 现金转化率经营现金流/净利润 | 10.25× | — |
| 过去12个月自由现金流最近4个季度 | $9.8M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $3.4M | $-46.1M | ||
| Q3 25 | $9.9M | $-117.4M | ||
| Q2 25 | $5.1M | $-76.4M | ||
| Q1 25 | $-1.3M | $-132.0M | ||
| Q4 24 | $403.0K | $-115.4M | ||
| Q3 24 | $1.9M | $-59.2M | ||
| Q2 24 | $-14.7M | $-82.2M | ||
| Q1 24 | $-792.0K | $-102.3M |
| Q4 25 | $1.1M | $-47.3M | ||
| Q3 25 | $8.4M | $-117.6M | ||
| Q2 25 | $2.7M | $-79.6M | ||
| Q1 25 | $-2.4M | $-133.8M | ||
| Q4 24 | $-444.0K | $-116.7M | ||
| Q3 24 | $419.0K | $-63.8M | ||
| Q2 24 | $-17.4M | $-83.4M | ||
| Q1 24 | $-3.2M | $-109.0M |
| Q4 25 | 3.4% | -133.1% | ||
| Q3 25 | 29.5% | -2272.5% | ||
| Q2 25 | 10.3% | -413.9% | ||
| Q1 25 | -9.5% | -907.4% | ||
| Q4 24 | -1.6% | -2567.7% | ||
| Q3 24 | 1.4% | -244.6% | ||
| Q2 24 | -60.6% | -578.5% | ||
| Q1 24 | -10.9% | -789.9% |
| Q4 25 | 7.7% | 3.5% | ||
| Q3 25 | 5.3% | 4.7% | ||
| Q2 25 | 8.8% | 16.4% | ||
| Q1 25 | 4.5% | 12.4% | ||
| Q4 24 | 3.1% | 28.6% | ||
| Q3 24 | 5.1% | 17.5% | ||
| Q2 24 | 9.4% | 8.2% | ||
| Q1 24 | 8.2% | 48.2% |
| Q4 25 | 10.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.48× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KVHI
| Services | $28.3M | 93% |
| Products | $2.2M | 7% |
RXRX
暂无分部数据
